Periodic monitoring Active

Key facts

  • In June 2025, 587 measles cases were reported by 15 countries in the EU/EEA. Eleven countries reported zero cases.
  • Overall, six measles-related deaths have been reported in the EU/EEA in 2025, two from France, one from the Netherlands and three from Romania.
  • Overall, case numbers decreased compared with the previous month; this is consistent with the seasonality of measles.

Overview

In June 2025, 26 countries reported measles data in the EU/EEA, with 587 measles cases reported by 15 countries. There were 11 countries that reported zero cases.

Overall, case numbers decreased compared with the previous month; which is consistent with the seasonality of the disease. The highest case counts were reported by Romania (292), France (74), Belgium (56) and Italy (52).

Between 1 July 2024 to 30 June 2025, 30 EU/EEA Member States reported a total of 14 401 cases of measles, 10 276 (71.4%) of which were laboratory confirmed. Of the 14 401 cases with known age, 6020 (41.8%) were in children under five years; 4 439 (30.8%) cases were aged 15 years or above. The highest notification rates were observed among infants under one year of age (481.1 cases per million) and children aged 1-4 years (256.8 cases per million)

Of 13 300 cases (92.4% of all cases) with a known age and vaccination status, 11 208 (84.3%) were unvaccinated, 1 164 (8.8%) were vaccinated with one dose of a measles-containing vaccine, 800 (6.0%) were vaccinated with two or more doses, and 107 (0.8%) were vaccinated with an unknown number of doses.

During the 12-month period, 11 deaths (case fatality rate (CFR): 0.1) attributable to measles were reported to ECDC by Romania (eight), France (two) and the Netherlands (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.

Complementary epidemic intelligence surveillance has been conducted, with data collection between 5 and 6 August 2025. Ongoing outbreaks or considerable increases were reported in Belgium (Flanders region), Germany (Bavaria region), and Romania. Sporadic cases have been reported in Austria, Czechia, Denmark, Estonia, Italy, Lithuania, the Netherlands, Poland, Slovakia, and Spain.

Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy and EpiPulse. Data presented in the two monthly reports may differ.

Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:

Austria reported 138 measles cases in 2025 and as of 30 July 2025, an increase of five cases since 2 July 2025. In the recent four weeks, cases have been reported from Vienna and Upper Austria. Relevant information was available for 128 cases, of which 33 were hospitalised (25.8%), including one patient being treated in intensive care unit.

Denmark reported five measles cases in 2025 as of 5 August 2025 (an increase of one since June).

France: according to the national public health authorities, the number of cases in the first half of 2025 (743 cases, including two deaths among immunocompromised patients) is already exceeding the number of cases reported in 2024 (483 cases; 0.58 cases per 100 000 population). Among these cases, 254 (34%) were hospitalised (including 11 in intensive care), 98 (13%) had a complication (including 58 pneumonia cases and one encephalitis case). The median age of the cases is 16.6 years. Among the subjects targeted for vaccination (aged over one year and born since 1980), for whom the vaccination status was known (n=470), 285 (61%) were unvaccinated or incompletely vaccinated, 171 (36%) were vaccinated with two doses, and 14 (3%) cases were vaccinated without the number of doses received being specified. Sixty-five departments in France (64%) reported at least one case during the period; no cases were reported in overseas territories. The five main departments affected are: Nord (17%), Bouches-du-Rhône (7%), Haute-Savoie (6%), Isère (5%), and Paris (4%).

At the national level, the number of reported cases appears to have peaked in March but remains at a high level. The increase is caused by transmission occurring due to either imported cases as well as locally acquired infections.

Germany reported 213 confirmed and probable measles cases in 2025 and as of 5 August 2025, an increase of six cases since 8 July 2025.

Greece reported two cases of measles in 2025 and as of 30 June 2025.

Hungary reported five cases of measles in 2025 and as of 27 July 2025. The last case was reported in week 28 of 2025 (mid-July 2025).

Italy: in 2025 and as of 30 June, there have been 391 cases reported, of which 52 cases reported in June. Twenty regions reported measles, with the majority of the cases observed in Sicily, Lombardy, Lazio and Emilia-Romagna. Almost half of the cases (48.8%) are 15 years of age or older (median 31 years of age), however highest incidence is seen in children under five years of age. Eighty-seven percent of the 370 with known vaccination status are unvaccinated.

Latvia reported one case of measles in 2025 and as of 31 May 2025.

The Netherlands reported 488 cases of measles as of 2 July 2025, an increase of 16 cases since 2 July 2025. The reports are mainly comprising of individual cases and several small clusters with transmission occurring within families and daycare centers. There is no indication of a national outbreak. In 2025, 53 cases were reported to have contracted measles abroad, with most of these infections occurring in Morocco (35). Other cases had travel histories to Greece, Romania, Viet Nam, Türkiye, Belgium, Uganda, Iran, Bosnia and Herzegovina, China and Malaysia. On 12 June 2025, RIVM reported the death from measles of an adult with a severe immune disorder.

Poland reported 60 measles cases in 2025 and as of 31 July, an increase of one case since 30 June 2025.

Romania reported 8 160 measles cases and eight deaths in 2025 and as of 31 July, an increase of 324 cases since June 2025. No new deaths were reported in this reporting period. A decreasing trend is observed in 2025, with fewer cases reported per month compared to the same period in 2024.

Spain reported 328 cases as of 27 July 2025 (309 cases reported as of 29 June 2025), of which 100 were imported and 87 were related to imported cases.

Epidemiological summary for EU/EEA outermost territories with relevant epidemic intelligence updates:

Réunion: On 17 July 2025, French authorities reported an autochthonous case of measles in a < 2-year-old infant. This is the first authochthonous case reported on the island since 2019.

Epidemiological summary for select countries outside of the EU/EEA with relevant epidemic intelligence updates:

England reported 674 laboratory confirmed cases from January to 31 July 2025, an increase of 145 cases since our last report on 3 July 2025. The majority of cases involve children under 10 years of age (69%).

According to the report by Africa CDC published on 3 August 2025, a total of 109 934 measles cases, of which 8 445 confirmed, and 775 deaths were reported in 18 countries: Cameroon, Chad, DRC, Ethiopia, Guinea, Kenya, Malawi, Mali, Mauritania, Morocco (44 372 cases and 95 deaths), Nigeria, Rwanda, Senegal, Somalia, South Africa, Sudan, Uganda and Zambia.

According to the WHO Pan American Health Organization (WHO PAHO) report published on 1 August 2025, 9 756 confirmed cases were reported by nine countries, of which the majority of cases are reported by Canada (4 394), Mexico (3 748), and the United States (US).

As of 6 August 2025, the US reported 1 356 confirmed measles cases in 2025, including three deaths in 41 jurisdictions. Ninety-two percent of the cases were unvaccinated or had an unknown vaccination status.

For more information on the provisional number of cases outside the EU/EEA region, please visit the WHO website.

The numbers provided to WHO for EU/EEA countries are from TESSy data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.

ECDC assessment

Since March 2025, an overall decrease in reported cases has been observed. A further decline in case numbers is expected over the summer months, in line with the known seasonality of measles.

However, continued vigilance is essential due to suboptimal vaccination coverage for measles-containing vaccines (MCV) in several EU/EEA countries, the likelihood of importation from areas with ongoing transmission, and increased travel and population movement during the holiday period.

Although most recent cases were acquired through local or community transmission, travel-related cases continue to be reported.

Actions

ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs that present measles surveillance data from EpiPulse Cases, which are routinely submitted by 30 EU/EEA countries.

ECDC urges EU/EEA public health authorities to focus on the following areas:

  • Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time, as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
  • Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
  • Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
  • Healthcare professionals should be fully vaccinated.
  • Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
  • Address barriers and engage with under-served populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
  • In light of the upcoming summer holiday season, travellers should check their vaccination status and consult their general practitioner to ensure they are up to date with recommended immunisations prior to departure.


ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.

Latest updates for this event

View all